Hackett, Neil R.
Weill Cornell Medicine,
United States
2025 Rank: 347296
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 1272 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 347296 | 354408 |
| Total Cites | 13329 | 14975 |
| H-index | 51 | 56 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 570 | 692 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 616 | 740 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 10778 | 11456 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.31 |
| Self-Citation Percentage |
10.99%
|
|
Hackett, Neil R.
Weill Cornell Medicine,
United States
2023 Rank: 306676
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 1071 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 306676 | 315933 |
| Total Cites | 12707 | 14303 |
| H-index | 49 | 53 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 548 | 663 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 591 | 708 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 10260 | 10921 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.31 |
| Self-Citation Percentage |
11.16%
|
|
Hackett, Neil R.
Weill Cornell Medicine,
United States
2022 Rank: 289143
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 988 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 289143 | 298901 |
| Total Cites | 12171 | 13751 |
| H-index | 46 | 51 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 509 | 627 |
| Number of Single+First+Last Authored Papers | 17 | 17 |
| Total Cites to Single+First+Last Authored Papers | 547 | 665 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 9832 | 10486 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.31 |
| Self-Citation Percentage |
11.49%
|
|
Hackett, Neil R.
Weill Cornell Medicine,
United States
2021 Rank: 278240
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 961 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 278240 | 290458 |
| Total Cites | 11874 | 13428 |
| H-index | 46 | 50 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 493 | 611 |
| Number of Single+First+Last Authored Papers | 17 | 17 |
| Total Cites to Single+First+Last Authored Papers | 529 | 647 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 9600 | 10240 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.31 |
| Self-Citation Percentage |
11.57%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.